- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
General Moly Inc. (TSX:GMO,NYSEMKT:GMO) announced that it’s closed the private placement it announced on December 23, 2014 for gross proceeds of $8.535 million.
General Moly Inc. (TSX:GMO,NYSEMKT:GMO) announced that it’s closed the private placement it announced on December 23, 2014 for gross proceeds of $8.535 million. The money will be used for general corporate purposes and for maintenance of the company’s Mt. Hope and Liberty projects.
As quoted in the press release:
The Company sold 85,350 units for $100 each. Each unit consists of one senior convertible note due 2019 (the ‘Notes’) with principal value of $100 and 100 five-year warrants to purchase the Company’s common stock at $1.00 per share. The Notes, which are senior to any General Moly debt obligations, mature on December 26, 2019, and have a 10% coupon rate payable quarterly. The Notes convert into common stock at a 20% discount to the greater of (i) the trailing 30-day volume weighted average price (‘VWAP’) at the date on which a Notice of Conversion is issued and (ii) the trailing 30-day VWAP as of December 22, 2014. Each Note will convert into a maximum of 100 shares per note, resulting in the issuance of 8,535,000 shares, or 9.3% of shares outstanding. General Moly’s executive management team and board of directors who participate in the offering will be restricted from converting at a price less than $0.32, the most recent closing price at the time that the Notes were issued.
Bruce D. Hansen, CEO of General Moly, commented:
The financing provides the Company with a bridge to a project financing for Mt. Hope while minimizing the dilution to our shareholders. The Private Placement included one $5 million block purchased by an investor with significant experience in the molybdenum sector, and General Moly’s executive management team and board of directors which invested over $2 million in aggregate. We believe that the investment made by our management team and board of directors provides a strong statement of support for the future prospects of General Moly.
Click here to read the full General Moly Inc. (TSX:GMO,NYSEMKT:GMO) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.